CNTA Centessa Pharmaceuticals plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CNTA

Price (delayed)

$39.815

Market cap

$6.16B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.79

Enterprise value

$6.22B

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 93
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7
Highlights
Centessa Pharmaceuticals's quick ratio has decreased by 36% YoY but it has increased by 10% QoQ
CNTA's equity is up by 26% YoY but it is down by 8% QoQ
The gross profit has plunged by 100% from the previous quarter and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of CNTA

CNTA stock price

How has the Centessa Pharmaceuticals stock price performed over time
Intraday
-0.09%
1 week
0.01%
1 month
0.29%
1 year
217.76%
YTD
59.2%
QTD
0.24%

Financial performance

How have Centessa Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$256.69M
Net income
-$250.64M
Gross margin
N/A
Net margin
N/A
The gross profit has plunged by 100% from the previous quarter and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year
The operating income has contracted by 31% YoY and by 24% from the previous quarter
The net income has contracted by 27% from the previous quarter and by 12% YoY

Price vs fundamentals

How does CNTA's price correlate with its fundamentals

Growth

What is Centessa Pharmaceuticals's growth rate over time

Valuation

What is Centessa Pharmaceuticals stock price valuation
P/E
N/A
P/B
12.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 23% QoQ but it rose by 4.8% YoY
CNTA's price to book (P/B) is 45% higher than its last 4 quarters average of 8.7
CNTA's equity is up by 26% YoY but it is down by 8% QoQ
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Efficiency

How efficient is Centessa Pharmaceuticals business performance
Centessa Pharmaceuticals's return on invested capital has increased by 35% YoY but it has decreased by 22% QoQ
Centessa Pharmaceuticals's return on assets has decreased by 20% QoQ and by 4.2% YoY
The company's return on equity fell by 19% QoQ and by 6% YoY

Dividends

What is CNTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CNTA.

Financial health

How did Centessa Pharmaceuticals financials performed over time
Centessa Pharmaceuticals's quick ratio has decreased by 36% YoY but it has increased by 10% QoQ
CNTA's current ratio is down by 34% year-on-year but it is up by 11% since the previous quarter
The debt is 76% smaller than the equity
CNTA's equity is up by 26% YoY but it is down by 8% QoQ
Centessa Pharmaceuticals's debt to equity has decreased by 20% YoY but it has increased by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.